This inventor holds 12 USPTO granted patents, plus 2 CIPO patents and 8 EPO patents. Top assignees: The United States of America as Represented by the Department of Health, The United States of America as Represented by the Secretary of, The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 1985-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Wheaton, MD (US) (1985)
- Bethesda, MD (US) (1989)
- Silver Spring, MD (US) (1994)
- Silverspring, MD (US) (1995)
- Silver Springs, MD (US) (1997 - 1999)
- Rockville, MD (US) (1996 - 2014)
Company Filing History:
5 out of 1,217 
3 out of 2,202 
3 out of 3,699 
Years Active: 1985-2014
Title: David J Fitzgerald: Innovator in Antibody-Toxin Fusion Proteins
Introduction
David J Fitzgerald is a notable inventor based in Silver Springs, MD (US). He has made significant contributions to the field of biotechnology, particularly in the development of recombinant antibody-toxin fusion proteins. With a total of seven patents to his name, Fitzgerald's work has the potential to impact therapeutic approaches in medicine.
Latest Patents
Fitzgerald's latest patents include a recombinant antibody-toxin fusion protein, which describes proteins that selectively kill cells bearing appropriate antigens or receptors. Another significant invention is the recombinant Pseudomonas exotoxin with increased activity. This invention focuses on producing and utilizing modified Pseudomonas-derived toxins that enhance toxicity and potency in therapeutic applications. Specifically, it relates to certain deletions in domain II of the amino acid sequence of Pseudomonas exotoxin, which is crucial for the toxin's natural proteolytic processing.
Career Highlights
Throughout his career, Fitzgerald has worked with esteemed organizations, including the United States of America as represented by the Department of Health and the United States of America as represented by the Secretary of Health. His innovative work has garnered attention and respect within the scientific community.
Collaborations
Fitzgerald has collaborated with notable colleagues such as Ira H Pastan and Mark C Willingham. These partnerships have likely contributed to the advancement of his research and the successful development of his patents.
Conclusion
David J Fitzgerald is a prominent figure in the field of biotechnology, with a focus on antibody-toxin fusion proteins. His innovative patents and collaborations highlight his significant contributions to medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile